Search results for "Angiopathy"

showing 10 items of 52 documents

Protein�A immunoadsorption therapy for refractory, mitomycin�C?associated thrombotic microangiopathy

2007

BACKGROUND: Mitomycin C–associated thrombotic microangiopathy (TMA) has a poor prognosis with limited therapeutic options. Most patients die within 4 months of diagnosis due to pulmonary or renal failure. Here, a patient resistant to total plasma exchange (TPE) and immunosuppressive therapy with glucocorticoids, rituximab, vincristine, and splenectomy who was successfully treated with protein A immunoadsorption is described. CASE REPORT: A 29-year-old woman developed a TMA after chemotherapy with mitomycin C. She presented with thrombocytopenia, pulmonary edema, hemolytic anemia with presence of schistocytes, and renal failure. Immediate TPE (>120 times) and immunosuppressive therapy with g…

AdultHemolytic anemiamedicine.medical_specialtyThrombotic microangiopathyMitomycinmedicine.medical_treatmentImmunologySplenectomyGastroenterologyInternal medicinemedicineHumansImmunology and AllergyStaphylococcal Protein AImmunoadsorptionImmunosorbent TechniquesSalvage TherapyChemotherapyPurpura Thrombotic Thrombocytopenicbusiness.industryImmunosuppressionHematologymedicine.diseaseSurgerySchistocyteTreatment OutcomeHemolytic-Uremic SyndromeFemaleRituximabbusinessmedicine.drugTransfusion
researchProduct

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

2020

Aims Renal changes in patients with myeloproliferative neoplasms (MPNs) or myelodysplastic syndrome (MDS)/MPNs have been addressed by few, respectively no, reports. The aim of this study was to focus on a systematic evaluation of renal biopsies in patients with MPNs or MDS/MPNs. Methods and results The cohort comprised 29 patients (23 men) aged 67 ± 11 years (mean ± standard deviation), diagnosed with chronic myeloid leukaemia (n = 5), polycythaemia vera (n = 9), primary myelofibrosis (n = 5), essential thrombocythaemia (n = 2), or chronic myelomonocytic leukaemia (n = 4), as well as MPNs or MDS/MPNs not otherwise specified (n = 4). Patients manifested with proteinuria (93%), partially in t…

AdultMale0301 basic medicinemedicine.medical_specialtyPolycythaemiaHistologyThrombotic microangiopathy610 MedizinRenal functionMesangial hypercellularityGastroenterologyPathology and Forensic MedicineNephropathyCohort Studies03 medical and health sciencesGlomerulonephritis0302 clinical medicineRisk FactorsNeoplasmshemic and lymphatic diseasesInternal medicine610 Medical sciencesmedicineHumansddc:610MyelofibrosisAgedAged 80 and overMyeloproliferative DisordersProteinuriaThrombotic Microangiopathiesbusiness.industryGlomerulonephritisGeneral MedicineMiddle Agedmedicine.diseaseMyelodysplastic-Myeloproliferative Diseases030104 developmental biologyMyelodysplastic Syndromes030220 oncology & carcinogenesisFemaleKidney Diseasesmedicine.symptombusiness
researchProduct

Microvascular abnormalities in patients with rheumatoid arthritis.

2006

Summary Microvascular involvement represents one of the first apparent steps in many autoimmune diseases such as rheumatoid arthritis (RA). Early in the disease, peripheral microangiopathy may be easily recognized and studied by videocapillaroscopy. The aim of this study has been to observe the differences in labial microcirculation between healthy patients and patients suffering from RA. A total of 30 healthy patients and 30 patients suffering from RA were examined. The patients with conditions known to compromise microcirculation, such as diabetes, hypertension, or some pharmacological treatments were not included in the study. All the patients were non-smokers. Labial capillaroscopy was …

AdultMalePathologymedicine.medical_specialtyDiseaseMicrocirculationArthritis RheumatoidReference ValuesDiabetes mellitusmedicineHumansIn patientLabial MucosaAgedbusiness.industryMicrocirculationMicroangiopathyGeneral MedicineMiddle Agedmedicine.diseasePeripheralRheumatoid arthritisBlood VesselsFemaleAnatomybusinessDevelopmental BiologyAnnals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
researchProduct

Pipestem capillaries in necrotizing myopathy revisited.

2012

Pipestem-capillaries in necrotizing myopathy, have been reported as a feature of a distinct type of myopathy. Here, we analyze four muscle biopsy specimens from patients exhibiting endomysial fibrosis associated with pipestem capillaries using histological and electronmicroscopic techniques. However, only one case displayed all of the originally described features, including necrotic fibres, capillary thickening and lack of a significant lymphocytic inflammation, while one case exhibited striking capillary pathology with minimal necrosis and absence of inflammation, and the other two cases were accompanied by additional pathological features. These data support the existence of a microangio…

AdultMalePathologymedicine.medical_specialtyNecrosisBiopsyContext (language use)InflammationComplement Membrane Attack ComplexBiologyNecrosisMuscular DiseasesBiopsymedicineHumansMyopathyMuscle SkeletalPathologicalCreatine KinaseGenetics (clinical)AgedAged 80 and overMuscle biopsymedicine.diagnostic_testMicroangiopathyAnatomyMiddle Agedmedicine.diseaseHypoxia-Inducible Factor 1 alpha SubunitCapillariesNeurologyPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptomNeuromuscular disorders : NMD
researchProduct

Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy

2008

Background: Pharmacological treatment for diabetic polyneuropathy (DP) has shown limited benefit; frequency-modulated electrical stimulation (FREMS) has shown positive results in pain control and nerve conduction velocity in DP. Objective: To investigate the effects of FREMS vs transcutaneous electrical nerve stimulation (TENS) on the release of vascular endothelial growth factor (VEGF) in Type 2 diabetic and in non-diabetic subjects. Methods: 10 non-diabetic [mean age 37±5 yr; females (F)/males (M): 6/4] and 10 Type 2 diabetic subjects (mean age 52±6 yr; F/M: 5/5) with DP underwent TENS (for 10 min) followed by 30 min interval without electrical stimulation, and then FREMS (for 10 min) ove…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyDiabetic neuropathyEndocrinology Diabetes and MetabolismNeural ConductionAction PotentialsPainElectric Stimulation TherapyStimulationTranscutaneous electrical nerve stimulationNerve conduction velocitylaw.inventionchemistry.chemical_compoundEndocrinologyDiabetic NeuropathiesForearmlawInternal medicineVasa nervorumHumansPain ManagementMedicineMotor Neuronsbusiness.industryMicroangiopathyMiddle Agedmedicine.diseaseVascular endothelial growth factorEndocrinologymedicine.anatomical_structurechemistryTranscutaneous Electric Nerve StimulationFemalebusiness
researchProduct

Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms.

1998

Some patients with typical angina and electrocardiographic evidence of ischemia have normal coronary angiograms. These patients have a reduced coronary flow reserve and abnormal endothelium-dependent vasodilator responses; this syndrome is known as microvascular angina. Among endothelium-derived peptides, endothelin-1 (ET-1) is a potent vasoconstrictor and an important modulator of microvascular function.Plasma ET-1 was measured in 13 patients with typical angina, instrumental evidence of ischemia, and normal arteriograms and in 20 normal control subjects.Mean concentration of ET-1 was 2.89+/-1.24 pmol/L in patients with angina and normal angiograms and 1.99+/-0.81 pmol/L in normal control …

AdultMalemedicine.medical_specialtyIschemiaRadioimmunoassayVasodilationBlood PressureCoronary AngiographyAngina PectorisAnginaElectrocardiographyInternal medicinemedicineHumanscardiovascular diseasesEndothelial dysfunctionRetrospective Studiesmedicine.diagnostic_testEndothelin-1business.industryMicroangiopathyCoronary flow reserveStroke VolumeMiddle Agedmedicine.diseaseEndothelin 1Vasoconstrictioncardiovascular systemCardiologyExercise TestFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyAmerican heart journal
researchProduct

Homocysteine levels in patients with primary and secondary Raynaud's phenomenon. Its association with microangiopathy severity

2013

The association between hyperhomocysteinemia (HHcy) and Raynaud's phenomenon (RP) remains a matter of debate. In 18 primary RP, 23 secondary RP and 41 controls, we investigated homocysteine (Hcy) levels along with biochemical and inflammatory parameters. The Hcy levels in both primary and secondary RP were elevated when compared with controls (p0.05 and p0.01, respectively). As age was higher in secondary RP as compared with controls (p0.01), both primary and secondary RP were age-matched with a corresponding control group, and with Hcy maintaining its statistical significance (p0.05). No differences in creatinine, B12 vitamin or folic acid were observed between groups (p0.05), or in the pr…

AdultVitaminHyperhomocysteinemiamedicine.medical_specialtyHomocysteinePhysiologyDiseaseGastroenterologyPathogenesisYoung Adultchemistry.chemical_compoundFolic AcidPhysiology (medical)Internal medicineHumansMedicineIn patientHomocysteineAgedSecondary Raynaud's Phenomenonbusiness.industryMicrocirculationMicroangiopathyRaynaud DiseaseHematologyMiddle Agedmedicine.diseaseCapillariesVitamin B 12chemistryFemaleCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.

2013

Raynaud's phenomenon (RP) is an episodic peripheral circulatory disorder characterized by local artery spams in subjects exposed to cold or emotional stress. It is not well-established whether RP patients show an altered rheological profile, mostly due to patient classification and clinical severity. We aimed to compare the hemorheological profile in patients with primary and secondary RP with a healthy control group. Eighteen primary RP, 22 secondary RP and 22 healthy controls, were included in the study. RP patients were also divided according to the presence of digital ulcers (7 with, 33 without). Biochemical and hemorheological variables were analyzed, including glucose, triglycerides, …

Adultmedicine.medical_specialtyPhysiologyBlood viscosityFibrinogenGastroenterologyErythrocyte aggregationYoung AdultPhysiology (medical)Internal medicinemedicineErythrocyte deformabilityHumansAgedbusiness.industryMicroangiopathyRaynaud DiseaseHematologyMiddle Agedmedicine.diseaseBlood ViscositySurgerymedicine.anatomical_structureCirculatory systemHemorheologyHemorheologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugArteryClinical hemorheology and microcirculation
researchProduct

Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients

2020

Systemic sclerosis (SSc) is an autoimmune disease characterized by endothelial dysfunction and fibroblasts activation. Microvascular disease may be easily observed by means of nailfold capillaroscopy. Recent evidences emphasized also the involvement of large-medium arteries in SSc, mainly in terms of increased stiffness of the vessel wall. The study aims to measure aortic root diameter in a cohort of SSc patients and to correlate echocardiographic findings with the capillaroscopic pictures. We analyzed the clinical records of 125 consecutive SSc patients (M/F 14/111, mean age 55 ± 12.7 years, median disease duration 11 years) referring in 3 second-level rheumatology centers. All subjects un…

Adultmedicine.medical_specialtyVasa vasorumMicroscopic Angioscopy03 medical and health sciences0302 clinical medicineRheumatologyInternal medicineMedicineAortic rootHumans030212 general & internal medicineEndothelial dysfunctionNailfold CapillaroscopyVideocapillaroscopyAged030203 arthritis & rheumatologyAutoimmune diseaseScleroderma Systemicintegumentary systembusiness.industryMicroangiopathyGeneral MedicineMiddle Agedmedicine.diseaseDilatationRheumatologyCapillariesmedicine.anatomical_structureCapillary densityNailsVasa vasorumCardiologySystemic sclerosisbusinessAortic root dilation
researchProduct

Secretory process: the role of age, autoimmunity and endocrinopathy

2020

Xerostomia is a common occurrence in older people, impairing their quality of life. When salivary gland function goes below 50%, patients show oral mucosal dryness and consequent problems on speaking and eating. They present oral health impairment. Their quality of life is compromised too. The prevalence of xerostomia is reported to be approximately 30% in people over 65 years old. Drug-induced xerostomia is the most common cause of dry mouth in elderly, because many older adults are taking at least one medication that causes salivary dysfunction. Among the autoimmune disease that can cause xerostomia, Sjogren’s syndrome (SS) is the most representative one in elderly. Dryness of oral mucosa…

AgingPediatricsmedicine.medical_specialtybusiness.industryIncidence (epidemiology)Diseasemedicine.diseaseDry mouthAngiopathystomatognathic diseasesmedicine.anatomical_structurestomatognathic systemQuality of lifeDiabetes mellitusmedicineTearsGeriatrics and GerontologyOral mucosamedicine.symptombusinessJournal of Gerontology and Geriatrics
researchProduct